Español
At OLIGOFASTX, we are dedicated to the development and research of therapeutic oligonucleotides for rare diseases seeking advances in personalised medicine, where each patient can receive treatments specifically designed for their unique genetic needs. Therefore, we strongly believe in the power of multidisciplinary research profiles to drive the development of personalised therapies by combining expertise […]
Monthly Archives: April 2024
10
Apr
Apr
At OLIGOFASTX, we work to develop therapeutic solutions for patients living with rare diseases. That is why World Health Day, celebrated every 7 April, is an occasion to reflect on the challenges and successes in global health. This year’s theme is “My Health, My Right”, highlighting the fundamental importance of equitable access to health services […]
01
Apr
Apr
In this eighth and final instalment of our #DiscoveringOligonucleotides series, we delve into the process of approval, registration and commercialisation of therapeutic oligonucleotides. Approval and registration The approval and registration process for therapeutic oligonucleotides, as for any other drug, is a critical step in their journey from the laboratory to the patient. This process involves […]